Language Selector

    Partner Search IMI for Call Topic IMI2

    Published on 17 August 2020
    Author: Sasha Hugentobler, National Contact Point Health

    Two Israeli SMEs and an Israeli scientific research Institute (IMBM) setting up a research proposal CARDYNAL (Cancer Rationaliced by a DYNamic AI modeL).

    An Israeli group of two SMEs (Genoox and Ibex Medical Analytics) and a scientific research Institute (IMBM) setting up a consortium for submission to IMI under call topic IMI2-2020-23-04 – "Optimal treatment for patients with solid tumours in Europe through Artificial Intelligence."

    Their planned project:
    Our project, CARDYNAL (CAncer Rationalized by a DYNamic AI modeL),will focus on integrating genomic and clinical data, as well as pathology imaging data, within dynamic-mechanistic mathematical models capturing longitudinal tumor evolvement, as an intertwined AI-based framework (e.g., a medical software device) for predicting patient response and personalizing/optimizing patient treatment and care in advanced lung, prostate, and breast cancers.

    More information and contact details here.